Clinical characteristics, genetic basis and healthcare resource utilisation and costs in patients with catecholaminergic polymorphic ventricular tachycardia: a …

CT Chung, S Lee, J Zhou, OHI Chou… - Reviews in …, 2022 - scholars.cityu.edu.hk
Background: This study examined the clinical characteristics, genetic basis, healthcare
utilisation and costs of catecholaminergic ventricular tachycardia (CPVT) patients from a …

104 Analysis of clinical characteristics, genetic basis, management and arrhythmic outcomes of patients with catecholaminergic polymorphic ventricular tachycardia …

G Tse, S Lee, KB Waleed, JMH Hui, I Lakhani - 2022 - heart.bmj.com
Introduction Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare cardiac
ion channelopathy. The aim of this study is to examine the clinical characteristics, genetic …

Arrhythmic outcomes in catecholaminergic polymorphic ventricular tachycardia

S Lee, J Zhou, K Jeevaratnam, I Lakhani, WT Wong… - medRxiv, 2021 - medrxiv.org
Introduction Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare cardiac
ion channelopathy. The aim of this study is to examine the genetic basis and identify pre …

[HTML][HTML] Clinical characteristics, outcomes, and genetic findings of patients with catecholaminergic polymorphic ventricular tachycardia in Hong Kong: A systematic …

JMH Hui, YHA Lee, K Hui, J Zhou, DI Satti… - Annals of Clinical …, 2022 - journals.lww.com
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare cardiac ion
channelopathy. This was the first systematic review of published works on the clinical …

Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: Disease penetrance and expression in cardiac ryanodine receptor mutation–carrying …

C van der Werf, I Nederend, N Hofman… - Circulation …, 2012 - Am Heart Assoc
Background—Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited
arrhythmia syndrome associated with mutations in the cardiac ryanodine receptor gene …

Genealogy and clinical course of catecholaminergic polymorphic ventricular tachycardia caused by the ryanodine receptor type 2 P2328S mutation

M Koponen, A Marjamaa, AM Tuiskula, M Viitasalo… - Plos one, 2020 - journals.plos.org
Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe
inherited arrhythmic disease associated with a risk of syncope and sudden cardiac death …

Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations

AK Broendberg, JC Nielsen, J Bjerre, LN Pedersen… - Heart, 2017 - heart.bmj.com
Objective The aim of this study was to characterise disease penetrance, course of disease
and use of antiarrhythmic medication and implantable cardioverter-defibrillator (ICD) therapy …

Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients

AV Postma, I Denjoy, J Kamblock, M Alders… - Journal of medical …, 2005 - jmg.bmj.com
Background: The aim of the study was to assess underlying genetic cause (s), clinical
features, and response to therapy in catecholaminergic polymorphic ventricular tachycardia …

Catecholaminergic Polymorphic Ventricular Tachycardia: Multiple Clinical Presentations of a Genetically Determined Disease

S Jurisic, A Medeiros-Domingo, F Berger… - Journal of Clinical …, 2023 - mdpi.com
Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare,
inherited heart rhythm disorder that is caused by variants in genes responsible for cardiac …

Clinical characteristics, genetic findings and arrhythmic outcomes of patients with catecholaminergic polymorphic ventricular tachycardia from China: A systematic …

J Leung, S Lee, J Zhou, K Jeevaratnam, I Lakhani… - Life, 2022 - mdpi.com
Introduction: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare
inherited cardiac ion channelopathy. The present study aims to examine the clinical …